Literature DB >> 8851618

Temporal variation in nephrotoxicity of low doses of isepamicin in rats.

Y Yoshiyama1, L Grenier, P Gourde, M Simard, L Lin, N J Morin, M G Bergeron, G Labrecque, D Beauchamp.   

Abstract

The temporal variation in the nephrotoxicity of low doses of isepamicin was studied in male Sprague-Dawley rats treated with a single daily intraperitoneal injection of saline (NaCl, 0.9%) or isepamicin (80 mg/kg of body weight) at either 0800, 1400, 2000, or 0200 h for 4 and 10 days. On day 10, the cellular regeneration (incorporation of [3H] thymidine into DNA of renal cortex) and cortical accumulation of isepamicin were significantly higher in animals treated at 1400 h than at 0200 h (P < 0.01). Immunogold labeling studies showed that isepamicin was essentially localized in the lysosomes of proximal tubular cells in all treated groups, but the density of the gold particles over the lysosomes was higher in animals treated at 1400 than at 0200 h. The results of the present study show that the renal toxicity of isepamicin was maximal at 1400 h (midlight period) and minimal at 0200 h (middark period).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851618      PMCID: PMC163205     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique.

Authors:  M Bendayan; M Zollinger
Journal:  J Histochem Cytochem       Date:  1983-01       Impact factor: 2.479

2.  In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.

Authors:  S A Kabins; C Nathan
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

3.  In vitro evaluation of a semisynthetic derivative of gentamicin B (Sch 21420).

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

4.  In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

5.  Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.

Authors:  G Laurent; P Maldague; M B Carlier; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

6.  Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin.

Authors:  S H Powell; W L Thompson; M A Luthe; R C Stern; D A Grossniklaus; D D Bloxham; D L Groden; M R Jacobs; A O DiScenna; H A Cash; J D Klinger
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

7.  Circadian variations in the renal toxicity of gentamicin in rats.

Authors:  C Pariat; P Courtois; J Cambar; A Piriou; S Bouquet
Journal:  Toxicol Lett       Date:  1988-02       Impact factor: 4.372

8.  Comparative nephrotoxicity of SCH 21420 and amikacin in rats.

Authors:  L I Rankin; F C Luft; M N Yum; R S Sloan; C B Dinwiddie; L L Isaacs
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

9.  The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure.

Authors:  W M Bennett; C E Plamp; D N Gilbert; R A Parker; G A Porter
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

10.  Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading.

Authors:  W M Bennett; W C Elliott; D C Houghton; D N Gilbert; J DeFehr; D A McCarron
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

View more
  3 in total

1.  Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration.

Authors:  M LeBrun; L Grenier; P Gourde; M G Bergeron; G Labrecque; D Beauchamp
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Chronopharmacokinetics of once daily dosed aminoglycosides in hospitalized infectious patients.

Authors:  Erik van Maarseveen; Wai Hong Man; Johannes Proost; Cees Neef; Daniël Touw
Journal:  Int J Clin Pharm       Date:  2015-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.